MSCAN has established a Clinical and Research Advisory Committee
(our CRAC Team).
Our CRAC Team reflects the complexity of skin cancer and covers relevant disciplines including dermatology, nursing, oncology, research, clinical trials and surgery. The CRAC team provide regular and ongoing advice to the MSCAN Board to:
- Provide feedback on MSCAN’s proposed projects
- Provide advice regarding key gaps in melanoma and skin cancer (including prevention, early detection, treatment and supportive care)
- Provide updates on pertinent matters for melanoma and skin cancer patients
- Review MSCAN materials as appropriate
- Provide feedback and insights into issues raised by patients in clinics/ appointments/ treatment rooms (i.e. what are the greatest needs and concerns for patients).
Meet MSCAN’s Clinical & Research Advisory Committee
Associate Professor Sid Baxi
Radiation Oncologist. Regional Medical Director at GenesisCare Gold Coast
Associate Professor Siddhartha (Sid) Baxi is a Radiation Oncologist and Regional Medical Director at GenesisCare Gold Coast. He works within the clinical oncology network of specialists at John Flynn Hospital, and in the Southport, Tweed and Pindara regions. His academic links are with Griffith University and Menzies School of Health Research. A/Prof Baxi is a member of the Faculty of Radiation Oncology branch of medical college, RANZCR, and Chair of the Targeting Cancer Campaign.
Professor Monika Janda
Behavioural scientist. University of Queensland
Professor Monika Janda is an internationally recognised behavioural scientist with a PhD and MPhil in psychology (Univ. Vienna), and postgraduate training in behaviour therapy and health psychology. Professor Janda is a member of the Australian Psychological Society, and the College of Health Psychologists. She is the Director of The University of Queensland’s Centre for Health Services Research, and now leads the NHMRC Centre of Research Excellence in Skin Imaging and Diagnosis (2021-25) and the NHMRC Synergy program Melanoma-ROSA (2022-26), which is developing Roadmap Options for Melanoma Screening in Australia.
Dr. Megan Lyle
Medical Oncologist. Cairns Hospital
Dr. Megan Lyle is a medical oncologist at the Liz Plummer Cancer Care Centre, Cairns Hospital and visiting medical officer at Far North Day Hospital and Cairns Private Hospitals. She holds a senior lecturer appointment with James Cook University. Dr. Lyle has a strong interest in melanoma research and has presented her research at national and international meetings, with her work published in major international peer reviewed journals, including the Journal of Clinical Oncology. Since moving to Cairns in 2014, Dr. Lyle has actively implemented strategies to improve the quality of care and access to therapies for melanoma patients in Far North Queensland. Dr. Lyle is currently principal investigator on many clinical trials and is chairperson of the Liz Plummer Cancer Care Centre High Risk Skin/Melanoma MDT.
Associate Professor Victoria Mar
Dermatologist. Director of the Victorian Melanoma Service at the Alfred Hospital
A/Prof Victoria Mar is an NHMRC Early Career Fellow at the School of Public Health and Preventive Medicine, Monash University. She has an interest in early diagnosis and surveillance of high-risk individuals. She a member of the Cancer Council Australia Melanoma Guidelines Working Group and Board member of the Melanoma and Skin Cancer Trials Group.
Dr. Donna Milne
Clinical Nurse Consultant, Peter MacCallum Cancer Centre. Co-Chair of the Melanoma & Skin Cancer Nurses Organisation
Donna is a registered nurse and is a clinical nurse consultant in the melanoma and skin service at Peter MacCallum Cancer Centre in Melbourne. Her clinical role involves symptom management, support and education of people with melanoma across the disease trajectory. She is also a nurse consultant team lead. Donna’s PhD investigated the perceptions of palliative care services held by people with advanced cancer. More recently Donna’s research has focused on understanding the experiences of patients receiving targeted and immune therapies for melanoma with a focus on distressing symptoms and side effects.
Professor Mark Shackleton
Director of Oncology at Alfred Health. Professor of Oncology at Monash University. Chair of Melanoma and Skin Cancer Trials Ltd.
After training in medical oncology and at the Ludwig Institute in Melbourne, Professor Mark Shackleton undertook PhD studies at the Walter and Eliza Hall Institute of Medical Research and post-doctoral work at the University of Michigan, USA. He has received several major prizes for his research: the 2006 Victorian Premier’s Award for Medical Research, a 2010 NHMRC Achievement Award, a 2011 Pfizer Australia Fellowship, and a 2016 Victorian Cancer Agency Clinical Research Fellowship. In 2012, he was awarded the Australian Science Minister’s Prize for Life Scientist of the Year.
Professor Peter Soyer
Chair and Director of the Dermatology Research Centre, The University of Queensland Diamantina Institute
Professor Soyer is the Chair and Director of the Dermatology Research Centre, The University of Queensland Diamantina Institute. His expertise is in dermato-oncology and dermatologic imaging. His research group’s main focus is skin cancer, both melanoma and keratinocyte skin cancer. He established and is co-leader of the Australian Skin and Skin Cancer Research Centre. He was co-president of the 9th World Congress of Melanoma, Brisbane, 2017. He is lead investigator of the NHMRC Centre of Research Excellence for the Study of Naevi and leads the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis. He is a MRFF Next Generation Clinical Researchers Program Practitioner Fellowship, and a Fellow of the Australian Academy of Health and Medical Sciences.
MSCAN’s Community Action Team
MSCAN is informed by a Community Action Team. It includes consumers with lived experience in both melanoma and non-melanoma skin cancer. They provide incredibly valuable insights and opinions into our work program.